tiprankstipranks
Advertisement
Advertisement
Azitra says Phase 1/2 ATR 04 trial remains on track for topline data this year
PremiumThe FlyAzitra says Phase 1/2 ATR 04 trial remains on track for topline data this year
1M ago
CEO says breadth of Azitra’s platform opens multiple attractive markets
Premium
The Fly
CEO says breadth of Azitra’s platform opens multiple attractive markets
1M ago
Azitra’s ATR12-351 Trial Completion Puts Rare-Disease Skin Drug on Investors’ Radar
Premium
Company Announcements
Azitra’s ATR12-351 Trial Completion Puts Rare-Disease Skin Drug on Investors’ Radar
1M ago
Azitra Adjusts 2026 Annual Shareholders Meeting Schedule
PremiumCompany AnnouncementsAzitra Adjusts 2026 Annual Shareholders Meeting Schedule
3M ago
Azitra files to sell 255.7M shares of common stock for holders
Premium
The Fly
Azitra files to sell 255.7M shares of common stock for holders
4M ago
Azitra granted new U.S. patent protecting ATR-12 program
Premium
The Fly
Azitra granted new U.S. patent protecting ATR-12 program
4M ago
Azitra Inc trading halted, news pending
PremiumThe FlyAzitra Inc trading halted, news pending
6M ago
Azitra Faces NYSE American Noncompliance and Delisting Risk
Premium
Company Announcements
Azitra Faces NYSE American Noncompliance and Delisting Risk
6M ago
Azitra Cancels Special Stockholder Meeting and Proposals
Premium
Company Announcements
Azitra Cancels Special Stockholder Meeting and Proposals
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100